Super Session 4 - New Collaboration Models in Life Sciences
Wednesday, September 9, 2015
•
S19
•
3:15 PM
>
4:15 PM
•
Super Session 4 - New Collaboration Models in Life Sciences
•
Plenary Room A2
Session hosted by Karolinska Institutet Holding
Increasing challenges and a firm desire to capture new opportunities are driving the development of new collaborative models between academia and industry as well as big and small companies.
Join this session to learn how Karolinska Institutet, Johnson & Johnson Innovation, AstraZeneca and a representative SME actually do to optimize their output in a rapidly changing life science landscape.
Moderator: Dr. Magnus Persson, seasoned scientist, investor and Life Science entrepreneur, CEO - Karolinska Institutet Holding, Chairman of the Board - Karolinska Institutet Innovations
Speakers:
Pr. Alexander von Gabain, Deputy Vice-Chancellor for Innovation and Corporate Alliances, Karolinska Institutet
Ms. Anna Gran, External Innovation Liaison Nordics, Johnson & Johnson Innovation
Mr. Jan-Olof Jacke, President, AstraZeneca AB
Ms. Kristin Sandereid, Executive Fund & Business Developer, Invent2
Dr. Hans T. Schambye, CEO, Galecto Biotech
|